Name | (2R)-2-[(3S,5R,10S,13R,14R)-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-enoic acid |
---|---|
Synonyms |
Trametenolic acid
(+)-trametenolic acid B Lanosta-8,24-dien-21-oic acid,3-hydroxy-,(3beta) 3beta-Hydroxylanosta-8,24-dien-21-oic acid |
Description | Trametenolic acid is a lanostanol glycoside that isolated from the EtOH extract of the fruit bodies of Laetiporus versisporus[1]. |
---|---|
Related Catalog | |
Target |
ERK1 ERK2 |
In Vitro | Trametenolic acid (1 mg/mL; 15-30 mins) induces the upregulation of autophagy-related proteins (Beclin-1, Atg12, and LC3) in B16-F1 cells by activating the ERK1/2 signaling pathway[1]. Trametenolic acid (1 mg/mL; 24 hours; B16-F1 cells) has dual synergic mechanisms to exert an anti-melanogenetic effect[1]. Trametenolic acid (0.1-4 mg/mL; 52 hours; B16-F1 cells) increase melanin synthesis by approximately 20% and 40% in cells transfected with siRNAs against mTOR and Atg5, respectively[1]. Western Blot Analysis[1] Cell Line: B16-F1 cells Concentration: 1 mg/mL Incubation Time: 15 and 30 mins Result: Increased the expression levels of phospho-p38, phospho-ERK1/2, Beclin-1, Atg12 and LC3 by approximately 46%, 10%, 48%, 126% and 49%, respectively. Western Blot Analysis[1] Cell Line: B16-F1 cells Concentration: 1 mg/mL Incubation Time: 24 hours Result: Increased the expression of ERK1/2 and p-ERK1/2 and decreased MITF, tyrosinase, and TRP 1 levels. |
References |
Density | 1.07±0.1 g/cm3 |
---|---|
Melting Point | 259-261 ºC |
Molecular Formula | C30H48O3 |
Molecular Weight | 456.70000 |
Exact Mass | 456.36000 |
PSA | 57.53000 |
LogP | 7.54380 |
Vapour Pressure | 3.26E-15mmHg at 25°C |
Storage condition | 2-8℃ |
Water Solubility | Insuluble (8.2E-6 g/L) (25 ºC) |